Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.040
-0.050 (-2.39%)
Jul 28, 2026, 3:39 PM EDT - Market open
Century Therapeutics Employees
Century Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 72 or -48.00% compared to the previous year.
Employees
78
Change (1Y)
-72
Growth (1Y)
-48.00%
Revenue / Employee
n/a
Profits / Employee
-$1,381,859
Market Cap
367.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 78 | -72 | -48.00% | 78 | 0 |
| Dec 31, 2024 | 150 | -15 | -9.09% | 140 | 10 |
| Dec 31, 2023 | 165 | -19 | -10.33% | 152 | 13 |
| Dec 31, 2022 | 184 | -4 | -2.13% | 163 | 21 |
| Dec 31, 2021 | 188 | 81 | 75.70% | 170 | 18 |
| Jun 30, 2021 | 121 | - | - | 121 | 0 |
| Mar 31, 2021 | 107 | - | - | 97 | 10 |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Sutro Biopharma | 133 |
| Enanta Pharmaceuticals | 120 |
| C4 Therapeutics | 104 |
| Scribe Therapeutics | 89 |
| Prelude Therapeutics | 79 |
| Atea Pharmaceuticals | 55 |
| Eupraxia Pharmaceuticals | 49 |
IPSC News
- 5 days ago - IHI Power Services Corp. Rebrands as Kyuden Energy Partners Following Acquisition by Japan's Kyuden Group - Business Wire
- 19 days ago - Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 - GlobeNewsWire
- 7 weeks ago - Century Therapeutics presents new preclinical data for CNTY-813 - TheFly
- 7 weeks ago - New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026 - GlobeNewsWire
- 2 months ago - Century Therapeutics initiated with an Outperform at Mizuho - TheFly
- 2 months ago - Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors - GlobeNewsWire
- 2 months ago - Century Therapeutics reports Q1 EPS (11c), consensus (17c) - TheFly
- 2 months ago - Century Therapeutics Reports First Quarter Financial Results and Business Updates - GlobeNewsWire